We are live on ! Find out more
MET.PRE icon

MetLife Inc 5.625% Series E Preferred Stock

4 hedge funds and large institutions have $8.44M invested in MetLife Inc 5.625% Series E Preferred Stock in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 34 (+1)

13% more capital invested

Capital invested by funds: $7.44M → $8.44M (+$998K)

0.11% more ownership

Funds ownership: 0.95%1.06% (+0.11%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CGH
1
Crossmark Global Holdings
Texas
$7.42M -$85.1K -3,445 -1%
WPP
2
Whalerock Point Partners
Rhode Island
$990K +$988K +40,000 New
PNC Financial Services Group
3
PNC Financial Services Group
Pennsylvania
$25.8K -$445 -18 -2%
OP
4
ORG Partners
Indiana
$173

MET.PRE Hedge Fund Activity: Q3 2024 in Review

4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q3 2024, worth a combined $8.44M — up 13% from $7.44M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MET.PRE positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Whalerock Point Partners, opening a new position worth an estimated $988K. The largest seller was Crossmark Global Holdings, cutting an estimated $85.1K.

  • 4 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q3 2024, up from 3 in Q2 2024.
  • Funds reported $8.44M of MetLife Inc 5.625% Series E Preferred Stock stock for Q3 2024, up 13% quarter-over-quarter.
  • 1 fund opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q3 2024 and 0 closed out, a net change of +1 holder.
  • The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q3 2024 was Whalerock Point Partners, an estimated $988K added.
  • The largest MetLife Inc 5.625% Series E Preferred Stock seller in Q3 2024 was Crossmark Global Holdings, an estimated $85.1K sold.

Based on aggregated 13F filings for Q3 2024.